Differentiation-inducing factor-1 suppresses the expression of c-myc in the human cancer cell lines

Journal of Pharmacological Sciences

Volumn 121, Issue 2, 2013, Pages 103-109

  Jingushi, Kentaro ^a   Nakamura, Toshihisa ^a   Takahashi Yanaga, Fumi ^a   Matsuzaki, Etsuko ^b   Watanabe, Yutaka ^c   Yoshihara, Tatsuya ^a   Morimoto, Sachio ^a   Sasaguri, Toshiyuki ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c EHIME UNIVERSITY   (Japan)

Author keywords

C Myc; Colon cancer cell; Differentiation inducing factor 1; Glycogen synthase kinase 3 ; Wnt catenin signaling pathway

Indexed keywords

ANTINEOPLASTIC AGENT; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; DIFFERENTIATION INDUCING FACTOR 1; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; GLYCOGEN SYNTHASE KINASE 3BETA INHIBITOR; MORPHOGEN; MYC PROTEIN; T CELL FACTOR PROTEIN; UNCLASSIFIED DRUG;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BINDING SITE; CANCER CELL; CANCER CELL CULTURE; CARCINOGENESIS; CELL PROLIFERATION; COLON CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA FLANKING REGION; DRUG EFFECT; GENE OVEREXPRESSION; GENE REPRESSION; HELA CELL; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION;

EID: 84874156223     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.12204FP     Document Type: Article

References (31)

1. Clevers H. Wnt/β-catenin signaling in development and disease. Cell. 2006;127:469-480.
2. Nelson WJ, Nusse R. Convergence of Wnt, β-catenin, and cadherin pathways. Science. 2004;303:1483-1487. (Pubitemid 38314410)
3. Moon RT, Bowerman B, Boutros M, Perrimon N. The promise and perils of Wnt signaling through β-catenin. Science. 2002; 296:1644-1646. (Pubitemid 34579151)
4. Akiyama T. Wnt/β-catenin signaling. Cytokine Growth Factor Rev. 2000;11:273-282.
5. Barker N, Clevers H. Mining the Wnt pathway for cancer therapeutics. Nat Rev Drug Discov. 2006;5:997-1014. (Pubitemid 44835127)
6. Nusse R, Varmus HE. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell. 1982;31:99-109.
7. Klaus A, Birchmeier W. Wnt signalling and its impact on development and cancer. Nat Rev Cancer. 2008;8:387-398. (Pubitemid 351589714)
8. Schneikert J, Behrens J. The canonical Wnt signalling pathway and its APC partner in colon cancer development. Gut. 2007;56: 417-425. (Pubitemid 46579774)
9. Wasylishen AR, Penn LZ. Myc: the beauty and the beast. Genes Cancer. 2010;1:532-541.
10. Meyer N, Penn LZ. Reflecting on 25 years with MYC. Nat Rev Cancer. 2008;8:976-990.
11. Zörnig M, Evan GI. Cell cycle: on target with Myc. Curr Biol. 1996;6:1553-1556. (Pubitemid 27050213)
12. Nesbit CE, Tersak JM, Prochownik EV. MYC oncogenes and human neoplastic disease. Oncogene. 1999;18:3004-3016. (Pubitemid 29276540)
13. Ponzielli R, Katz S, Barsyte-Lovejoy D, Penn LZ. Cancer therapeutics: targeting the dark side of Myc. Eur J Cancer. 2005;41:2485-2501. (Pubitemid 41540625)
14. Morris HR, Taylor GW, Masento MS, Jermyn KA, Kay RR. Chemical structure of the morphogen differentiation inducing factor from Dictyostelium discoideum. Nature. 1987;328:811-814. (Pubitemid 17125958)
15. Morris HR, Masento MS, Taylor GW, Jermyn KA, Kay RR. Structure elucidation of two differentiation inducing factors (DIF-2 and DIF-3) from the cellular slime mould Dictyostelium discoideum. Biochem J. 1988;249:903-906.
16. Takahashi-Yanaga F, Taba Y, Miwa Y, Kubohara Y, Watanabe Y, Hirata M, et al. Dictyostelium differentiation-inducing factor-3 activates glycogen synthase kinase-3β and degrades cyclin D1 in mammalian cells. J Biol Chem. 278;2003:9663-9670. (Pubitemid 36800463)
17. Yasmin T, Takahashi-Yanaga F, Mori J, Miwa Y, Hirata M, Watanabe Y, et al. Differentiation-inducing factor-1 suppresses gene expression of cyclin D1 in tumor cells. Biochem Biophys Res Commun. 2005;338:903-909. (Pubitemid 41597727)
18. Matsuzaki E, Takahashi-Yanaga F, Miwa Y, Hirata M, Watanabe Y, Sato N, et al. Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines. J Bone Miner Res. 2006;21:1307-1316. (Pubitemid 44128344)
19. Takahashi-Yanaga F, Mori J, Matsuzaki E, Watanabe Y, Hirata M, Miwa Y, et al. Involvement of GSK-3β and DYRK1B in differentiation-inducing factor-3-induced phosphorylation of cyclin D1 in HeLa cells. J Biol Chem. 2006;281:38489-38497. (Pubitemid 46041973)
20. 286 in squamous cell carcinoma. Exp Cell Res. 2005;310:426-433. (Pubitemid 41457345)
21. Yoshihara T, Takahashi-Yanaga F, Shiraishi F, Morimoto S, Watanabe Y, Hirata M, et al. Anti-angiogenic effects of differentiation-inducing factor-1 involving VEGFR-2 expression inhibition independent of the Wnt/β-catenin signaling pathway. Mol Cancer. 2010;9:245.
22. Jingushi K, Takahashi-Yanaga F, Yoshihara T, Shiraishi F, Watanabe Y, Hirata M, et al. DIF-1 inhibits the Wnt/β-catenin signaling pathway by inhibiting TCF7L2 expression in colon cancer cell lines. Biochem Pharmacol. 2012;83:47-56.
23. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, et al. Identification of c-MYC as a target of the APC pathway. Science. 1998;281:1509-1512. (Pubitemid 28425575)
24. Gregory MA, Qi Y, Hann SR. Phosphorylation by glycogen synthase kinase-3 controls c-myc proteolysis and subnuclear localization. J Biol Chem. 2003;278:51606-51612. (Pubitemid 38020405)
25. Yada M, Hatakeyama S, Kamura T, Nishiyama M, Tsunematsu R, Imaki H, et al. Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7. EMBO J. 2004;23:2116-2125. (Pubitemid 38737738)
26. Hoeflich KP, Luo J, Rubie EA, Tsao MS, Jin O, Woodgett Jr. Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation. Nature. 2000;406:86-90. (Pubitemid 30460216)
27. Cohen P, Frame S. The renaissance of GSK3. Nat Rev Mol Cell Biol. 2001;2:69-76.
28. Zeller KI, Jegga AG, Aronow BJ, O'Donnell KA, Dang CV. An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets. Genome Biol. 2003;4:R69.
29. 1 cyclin-cdk complexes. EMBO J. 1995;14:4814-4826.
30. Mateyak MK, Obaya AJ, Sedivy JM. c-Myc regulates cyclin D-Cdk4 and-Cdk6 activity but affects cell cycle progression at multiple independent points. Mol Cell Biol. 1999;19:4672-4683. (Pubitemid 29289505)
31. Sekine S, Shibata T, Sakamoto M, Hirohashi S. Target disruption of the mutant β-catenin gene in colon cancer cell line HCT116: preservation of its malignant phenotype. Oncogene. 2002;21: 5906-5911. (Pubitemid 35007241)